mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.04 |